Regulatory

Connecticut notice says Glenmark generic-drug settlement could pay eligible purchasers

Atlas Watchline · August 24, 2026

Key facts

What happened

Notice says an additional settlement has been reached involving some generic prescription drug manufacturers

Key facts

Why it matters

The settling defendant identified is Glenmark Pharmaceuticals, Inc., USA

Key facts

The details

Lawsuits continue against the listed non-settling defendants, including Actavis, Amneal, Ascend, Aurobindo, Breckinridge, Citron, Dr. Reddy's,…

Atlas Watchline

Read the full report

A Connecticut attorney general notice says a new generic-drug antitrust settlement with Glenmark Pharmaceuticals, Inc., USA…

Read on Atlas Watchline

Read on Atlas Watchline